Literature DB >> 21898243

Enhancing antigen cross-presentation and T-cell priming by complexing protein antigen to recombinant large heat-shock protein.

Xiang-Yang Wang1, Huanfa Yi, Xiaofei Yu, Damin Zuo, John R Subjeck.   

Abstract

Large heat-shock proteins (HSPs), including hsp110 and grp170, are unique immunochaperones capable of carrying and introducing antigens into professional antigen-presenting cells for efficient cross-presentation. Therefore, reconstituted chaperone complexes of large HSPs and protein antigen may be exploited for augmentation of an antigen-specific immune response. The methods for the preparation of the recombinant protein antigen chaperone complex and characterization of its T-cell priming capability in both in vitro and in vivo settings are described.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21898243      PMCID: PMC3271356          DOI: 10.1007/978-1-61779-295-3_21

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  22 in total

Review 1.  Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses.

Authors:  Pramod Srivastava
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

2.  HSP70 as endogenous stimulus of the Toll/interleukin-1 receptor signal pathway.

Authors:  Ramunas M Vabulas; Parviz Ahmad-Nejad; Sanghamitra Ghose; Carsten J Kirschning; Rolf D Issels; Hermann Wagner
Journal:  J Biol Chem       Date:  2002-02-12       Impact factor: 5.157

3.  CD91: a receptor for heat shock protein gp96.

Authors:  R J Binder; D K Han; P K Srivastava
Journal:  Nat Immunol       Date:  2000-08       Impact factor: 25.606

4.  Immunoprotective activities of multiple chaperone proteins isolated from murine B-cell leukemia/lymphoma.

Authors:  M Graner; A Raymond; D Romney; L He; L Whitesell; E Katsanis
Journal:  Clin Cancer Res       Date:  2000-03       Impact factor: 12.531

5.  Development of a recombinant HSP110-HER-2/neu vaccine using the chaperoning properties of HSP110.

Authors:  Masoud H Manjili; Robert Henderson; Xiang-Yang Wang; Xing Chen; Ying Li; Elizabeth Repasky; Latif Kazim; John R Subjeck
Journal:  Cancer Res       Date:  2002-03-15       Impact factor: 12.701

Review 6.  The hsp110 and Grp1 70 stress proteins: newly recognized relatives of the Hsp70s.

Authors:  D P Easton; Y Kaneko; J R Subjeck
Journal:  Cell Stress Chaperones       Date:  2000-10       Impact factor: 3.667

7.  Characterization of heat shock protein 110 and glucose-regulated protein 170 as cancer vaccines and the effect of fever-range hyperthermia on vaccine activity.

Authors:  X Y Wang; L Kazim; E A Repasky; J R Subjeck
Journal:  J Immunol       Date:  2001-01-01       Impact factor: 5.422

8.  Targeted immunotherapy using reconstituted chaperone complexes of heat shock protein 110 and melanoma-associated antigen gp100.

Authors:  Xiang-Yang Wang; Xing Chen; Masoud H Manjili; Elizabeth Repasky; Robert Henderson; John R Subjeck
Journal:  Cancer Res       Date:  2003-05-15       Impact factor: 12.701

9.  Involvement of LOX-1 in dendritic cell-mediated antigen cross-presentation.

Authors:  Yves Delneste; Giovanni Magistrelli; Jean Gauchat; Jean Haeuw; Jean Aubry; Kayo Nakamura; Naoko Kawakami-Honda; Liliane Goetsch; Tatsuya Sawamura; Jean Bonnefoy; Pascale Jeannin
Journal:  Immunity       Date:  2002-09       Impact factor: 31.745

10.  Hsp110 and Grp170, members of the Hsp70 superfamily, bind to scavenger receptor-A and scavenger receptor expressed by endothelial cells-I.

Authors:  John G Facciponte; Xiang-Yang Wang; John R Subjeck
Journal:  Eur J Immunol       Date:  2007-08       Impact factor: 5.532

View more
  8 in total

1.  Scavenger receptor A restrains T-cell activation and protects against concanavalin A-induced hepatic injury.

Authors:  Daming Zuo; Xiaofei Yu; Chunqing Guo; Hongxia Wang; Jie Qian; Huanfa Yi; Xiao Lu; Zhi-Ping Lv; John R Subjeck; Huiping Zhou; Arun J Sanyal; Zhengliang Chen; Xiang-Yang Wang
Journal:  Hepatology       Date:  2013-01       Impact factor: 17.425

2.  A multifunctional chimeric chaperone serves as a novel immune modulator inducing therapeutic antitumor immunity.

Authors:  Xiaofei Yu; Chunqing Guo; Huanfa Yi; Jie Qian; Paul B Fisher; John R Subjeck; Xiang-Yang Wang
Journal:  Cancer Res       Date:  2013-01-18       Impact factor: 12.701

3.  Enhanced antitumoral efficacy and immune response following conditionally replicative adenovirus containing constitutive HSF1 delivery to rodent tumors.

Authors:  Rong Fan; Cheng Wang; Yang Wang; Ping Ren; Pingping Gan; Hui Ji; Zian Xia; Suiyu Hu; Qiongyao Zeng; Wei Huang; Yebin Jiang; Xi Huang
Journal:  J Transl Med       Date:  2012-05-21       Impact factor: 5.531

Review 4.  Dendritic cell-based vaccination in cancer: therapeutic implications emerging from murine models.

Authors:  Soledad Mac Keon; María Sol Ruiz; Silvina Gazzaniga; Rosa Wainstok
Journal:  Front Immunol       Date:  2015-05-20       Impact factor: 7.561

5.  Enhanced endoplasmic reticulum entry of tumor antigen is crucial for cross-presentation induced by dendritic cell-targeted vaccination.

Authors:  Hongxia Wang; Xiaofei Yu; Chunqing Guo; Daming Zuo; Paul B Fisher; John R Subjeck; Xiang-Yang Wang
Journal:  J Immunol       Date:  2013-11-11       Impact factor: 5.426

6.  Nuclear heat shock protein 110 expression is associated with poor prognosis and chemotherapy resistance in gastric cancer.

Authors:  Akiharu Kimura; Kyoichi Ogata; Bolag Altan; Takehiko Yokobori; Munenori Ide; Erito Mochiki; Yoshitaka Toyomasu; Norimichi Kogure; Toru Yanoma; Masaki Suzuki; Tuya Bai; Tetsunari Oyama; Hiroyuki Kuwano
Journal:  Oncotarget       Date:  2016-04-05

Review 7.  Unfolding the Role of Large Heat Shock Proteins: New Insights and Therapeutic Implications.

Authors:  Daming Zuo; John Subjeck; Xiang-Yang Wang
Journal:  Front Immunol       Date:  2016-03-01       Impact factor: 7.561

Review 8.  Immunogenic Effect of Hyperthermia on Enhancing Radiotherapeutic Efficacy.

Authors:  Sungmin Lee; Beomseok Son; Gaeul Park; Hyunwoo Kim; Hyunkoo Kang; Jaewan Jeon; HyeSook Youn; BuHyun Youn
Journal:  Int J Mol Sci       Date:  2018-09-17       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.